Volunteers wearing face masks as a precaution against the coronavirus clear the debris left over by tourists at Maidan, the city s largest open space in Kolkata, India, Sunday, Jan. 3, 2021. (AP Photo/Bikas Das)
A roadside barber wearing mask as a precaution against the coronavirus gives hair cut to a man as others wait for their turn in Mumbai, India, Sunday, Jan. 3, 2021. (AP Photo/Rafiq Maqbool) Previous Next
Sunday, January 03, 2021 11:50 am
India OKs AstraZeneca and locally made COVID-19 vaccines
ANIRUDDHA GHOSAL and SHEIKH SAALIQ | Associated Press
NEW DELHI – India authorized two COVID-19 vaccines on Sunday, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country.
Dr Gangandeep Kang, noted vaccine expert and AIDAN have questioned the claim that Covaxin would work against the UK strain of Covid pointing out that there was no data or scientific basis to back the claim. What is the local efficacy data on the basis of which the expert committee recommended approval for the two vaccines? It is shocking that while Bharat Biotech is struggling to complete recruitment of volunteers for phase-3 trial, the approval was given. So what did the SEC base the approval on? asked Dr Amar Jesani, editor of the Indian Journal of Medical Ethics. We need to wait for at least the early results from that Bharat Biotech phase-3 trial before approval. Yes, there is a pandemic, and we need vaccines. But it is equally important that the public have absolute trust in a vaccine that is approved, said Dr JN Rao, an independent public health physician, researcher, and visiting professor at Staffordshire University.
AIDAN asks DCGI to withdraw approval for Bharat Biotech s Covaxin
By IANS |
Published on
Sun, Jan 3 2021 1:42 IST |
0 Views
New Delhi: A beneficiary undergoes a mock immunisation process at a Daryaganj dispensary as part of the COVID-19 dry run for immunization activity in New Delhi, on Jan 2, 2021. The central government plans to vaccinate nearly 30 crore people in the f. Image Source: IANS News
New Delhi, Jan 3 : The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC s recommendation to grant REU approval to Bharat Biotech s COVAXIN in clinical trial mode and specially in the context of infection by mutant strains .
Serum Institute s COVID-19 vaccine up for emergency approval downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.